Hemophilia A. Considerations in the dental management of pediatric patients. A case report.
Abstract
It comes to consulting the Faculty of Dentistry at the University of Nuevo León pediatric male patient of 9 years 10 months, who was admitted with a presumptive diagnosis of hemophilia due to a subsequent persistent bleeding to treatment with steel crowns made in an earlier appointment. Interconsultation is performed with the hematologist who by laboratory examinations notice decreased coagulation factor VIII confirming the diagnosis of hemophilia A. It plans and conducts comprehensive treatment dental team with the hematologist who said that patients in hospitals with the replacement of missing clotting factor is prepared by cryo precipitates or with concentrated factor VIII intravenously before and after his dental intervention. The aim of the article is to highlight that hemophilia can be a disease detected during dental surgery in some patients and for it to be successfully treated with multidisciplinary management protocol is required between hematologists and dentists.
Keywords: Treatment, patient, child, hemophilia A.
Hemofilia tipo A. Consideraciones en el manejo odontológico de pacientes infantiles. Reporte de un caso clínico.
Se presenta a consulta en la Facultad de Odontología de la Universidad Autónoma de Nuevo León paciente masculino pediátrico de 9 años 10 meses, el cual ingresa con un diagnóstico de presunción de hemofilia debido a un sangrado persistente posterior al tratamiento con coronas de acero realizadas en una cita anterior.Se efectúa interconsulta con el hematólogo quien mediante exámenes de laboratorio observa una disminución del factor VIII de coagulación lo que confirma el diagnóstico de hemofilia tipo A. Se planea y realiza el tratamiento integral odontológico en equipo con el hematólogo quien indica que se prepare al paciente a nivel hospitalario con la reposición del factor de coagulación faltante a través de crio precipitados o mediante concentrado del factor VIII por vía intravenosa previo y posterior a su intervención dental. El objetivo del artículo es destacar que la hemofilia puede ser una enfermedad detectada durante la consulta dental en algunos pacientes y que para que éstos sean tratados con éxito se requiere un protocolo del manejo multidisciplinario entre hematólogos y odontólogos.
Palabras claves: Tratamiento, paciente, infantil, hemofilia A.
References
2. Furie B, Furie BC. Molecular basis of blood coagulation. Hematology. Basic principles and practice. 5th Edition. Philadelphia, USA: Churchill Livingstone Elsevier; 2009.
3. Mantilla J, Beltrán CP, Jaloma ARJ. Diagnóstico molecular en pacientes y portadoras de hemofilia A y B. Gac Med Mex 2005; 141(1): 69-71
4. Hu C, Cela RG, Suzuki M, Lee B, Lipshutz GS. Neonatal helper-dependent adenoviral vector gene therapy mediates correction of hemophilia A and tolerance to human factor VIII. Proc Natl Acad Sci USA 2011; 108(5): 2082-7.
5. Montgomery RR, Shi Q. Alternative strategies for gene therapy of hemophilia. Hematology Am Soc Hematol Educ Program. 2010; 20(10): 197-202.
6. Secretaría de Salud México. Diagnóstico y tratamiento de Hemofilia Pediátrica México: Secretaría de Salud; 2009. Actualización 2012.
7. Kessler C. Hemorrhagic disorders: Coagulation factor deficiencies. In: Goldman L , Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, USA: Saunders Elsevier; 2007.
8. Valentino LA, Cooper DL, Goldstein B. Surgical experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX. Haemophilia 2011; 17(4): 579-89.
9. Fischer K, Pouw ME, Lewandowski D, Janssen MP, van den Berg HM, van Hout BA. A modeling approach to evaluate long-term outcome of prophylactic and on demand treatment strategies for severe hemophilia A. Haematologica 2011; 96(5): 738-43.
10. Gringeri A, Lundin B, von Mackensen S, Mantovani L, Mannucci PM. A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study). J Thromb Haemost 2011; 9(4): 700-10.
11. Gupta A, Epstein JB, Cabay RJ. Bleeding disorders of importance in dental care and related patient management. J Can Dent Assoc 2007; 73(1): 77-83.
12. Pipe SW. Hemophilia: new protein therapeutics. Hematology Am Soc Hematol Educ Program 2010; 20(10): 203-9
13. Maclean PS, Richards M, Williams M, Collins P, Liesner R, Keeling DM, Yee T, Will AM, Young D, Chalmers EA. Treatment related factors and inhibitor development in children with severe haemophilia A. Haemophilia 2011; 17(2): 282-7.
14. Négrier C, Shapiro A, Berntorp E, Pabinger I, Tarantino M, Retzios A, Schroth P, Ewenstein B. Surgical evaluation of a recombinant factor VIII prepared using a plasma/albumin-free method: efficacy and safety of Advate in previously treated patients. Thromb Haemost 2008; 100(2): 217-23
15. Franchini M, Tagliaferri A, Mengoli C, Cruciani M. Cumulative inhibitor incidence in previously untreated patients with severe hemophilia A treated with plasma-derived versus recombinant factor VIII concentrates: a critical systematic review. Crit Rev Oncol Hematol 2012; 81(1): 82-93.
16. Gómez-Moreno G, Cañete-Sánchez ME, Guardia J, Castillo-Naveros T, Calvo-Guirado JL. Orthodontic management in patients with haemophilia. About two clinical cases. Med Oral Patol Oral Cir Bucal 2010;15(3): e463-6.
17. World Federation of Hemofilia. Tratamiento odontológico de pacientes con inhibidores del factor VIII o factor IX. 2008, N°45.
18. Bravo L, Muñoz D. Consideraciones en el tratamiento odontológico de pacientes pediátricos con Hemofilia. Reporte de un caso clínico. J Oral Res 2012; 1(2): 86-9.
19. González GE, Esquivel DL. Tratamiento odontológico en niños con trastornos de la hemostasia. Revisión de la literatura y recomendaciones para la clínica. Univ Odontol 2011; 30(64): 19-29.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. © 2024.
